Invisible Ink: Writing Considerations for a Transparent World
Tell a Friend About This EventTell a Friend

Member $20 | Non-member $75

When: Wednesday, September 16, 2020
12:00 PM - 1:00 PM EDT
Where: Online (Live Webinar)
United States
Presenter: Nicole Hinton

Online registration is closed.
« Go to Upcoming Event List  

Your webinar registration includes access to the recording in AMWA Online Learning.

Evolving global regulations require greater transparency in all aspects of clinical trial documentation. To effectively meet these new standards, industry must change the way clinical trial documents are written.  Medical writers have a crucial role in helping to lead efforts in the development of disclosure-ready clinical trial documents. This webinar will provide an overview of current transparency regulations and their impact on the disclosure of clinical trial documents.  It will provide attendees with insights on how to develop and apply efficient approaches to support greater compliance.

Learning Objectives

After participating in this webinar, participants should be able to

  • Reference the key regulations driving clinical trial transparency
  • Define the meaning of a disclosure-ready document
  • Apply approaches to incorporate transparency-readiness into authored documents

Target Audience: Regulatory writers at all levels of experience

About the Presenter

Nicole Hinton has more than 20 years’ experience in the pharmaceutical industry.  Since 2013, she has been involved with clinical trial disclosure and transparency and is currently the Director of Clinical Trial Transparency at Ultragenyx.

Contact Us

American Medical Writers Association
30 West Gude Drive, Suite 525
Rockville, MD 20850-4347

phone:  240. 238. 0940
fax:        301. 294. 9006

About Us
Contact AMWA Staff
© 2020 AMWA / Policies